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Introduction
Traffic of macromolecules between the cytosol and the nucleus 
occurs through nuclear pore complexes (NPCs). Each NPC is 
composed of multiple copies of 30 different proteins called 
nucleoporins, which form a central transport channel that per­
forates the nuclear envelope, eight filaments that protrude from 
the cytoplasmic face of the pore, and eight filaments that con­
verge into a basket structure at the nuclear side of the pore 
(Strambio­De­Castillia et al., 2010). Nucleoporins with phenyl­
alanine­glycine (FG) repeats line the central channel, where 
they create a permeability barrier for larger macromolecules 
and contribute to transport receptor–mediated traffic through 
the NPC (Terry and Wente, 2009). Transport receptors bind to 
NLSs or nuclear export signals (NESs) in macromolecules to be 
transported and modulate cargo translocation across the NPC 
via sequential FG nucleoporin interactions. Most transport   
receptors belong to a family of related proteins, which in humans 
consists of >21 members, including the protein import receptors 
importin­ and transportin 1 and the protein export receptor 
Crm1 (Chook and Suel, 2010).
RanGTPase regulates the ability of nuclear transport factors 
to bind and release cargo (Wente and Rout, 2010). Import receptor–
cargo complexes reaching the nuclear face of the NPC bind 
RanGTP, resulting in cargo release. On the other hand, binding of 
export receptors to RanGTP promotes cargo loading rather than 
release. As export complexes arrive at the cytoplasmic face of the 
pore, hydrolysis of RanGTP to RanGDP triggers cargo release into 
the cytoplasm. RanGTP hydrolysis in the cytosol is activated by 
the RanGTPase­activating protein RanGAP1 and is facilitated by 
binding to RanBP1. In the nucleus, Ran is maintained in the GTP­
bound form by the guanine nucleotide exchange factor RCC1.
R
anBP2/Nup358,  the  major  component  of  the   
cytoplasmic filaments of the nuclear pore complex 
(NPC), is essential for mouse embryogenesis and is 
implicated in both macromolecular transport and mitosis, 
but its specific molecular functions are unknown. Using 
RanBP2  conditional  knockout  mouse  embryonic  fibro-
blasts and a series of mutant constructs, we show that 
transport, rather than mitotic, functions of RanBP2 are re-
quired for cell viability. Cre-mediated RanBP2 inactivation 
caused cell death with defects in M9- and classical nuclear 
localization signal (cNLS)–mediated protein import, nuclear 
export signal–mediated protein export, and messenger   
ribonucleic acid export but no apparent mitotic failure.   
A short N-terminal RanBP2 fragment harboring the NPC-
binding domain, three phenylalanine-glycine motifs, and 
one Ran-binding domain (RBD) corrected all transport   
defects and restored viability. Mutation of the RBD within 
this fragment caused lethality and perturbed binding to 
Ran guanosine triphosphate (GTP)–importin-, accumula-
tion of importin- at nuclear pores, and cNLS-mediated 
protein import. These data suggest that a critical function 
of  RanBP2  is  to  capture  recycling  RanGTP–importin- 
complexes at cytoplasmic fibrils to allow for adequate 
cNLS-mediated cargo import.
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been established. To examine this, we generated RanBP2 condi­
tional knockout MEFs by intercrossing RanBP2
+/F mice. We 
created these mice by interbreeding our RanBP2 hypomorphic 
mice (Dawlaty et al., 2008) with Flp recombinase transgenic 
mice (Fig. 1 A). Independent RanBP2
F/F MEF lines were im­
mortalized by expression of SV40 large T antigen and then 
transduced with pTSIN­Cre lentivirus to establish RanBP2
/ 
MEFs. Progressive cell death started on day 5 after transduc­
tion, resulting in a complete loss of viable cells between days 8 
and 10 (Fig. 1 B). Western blot analysis of MEF extracts pre­
pared at various days after lentiviral transduction showed that 
RanBP2 protein was undetectable by day 6 (Fig. 1 C). Consis­
tent with this, RanBP2
F/F MEFs at day 6 after Cre expression, 
designated as RanBP2
/ (D6) MEFs, showed no detectable 
nuclear rim staining for RanBP2 (Fig. 1 D). SUMO1­conjugated 
RanGAP1, whose association with the NPC is known to be de­
pendent on RanBP2 (Matunis et al., 1998), was also undetect­
able (Fig. 1, E and F). SUMO1­RanGAP1 levels at the nuclear 
envelope were strongly decreased in RanBP2
/ (D6) MEFs 
(Fig. 1 G), strengthening the notion that SUMO1­RanGAP1 re­
quires RanBP2 for protection against SUMO­isopeptidase ac­
tivity (Zhang et al., 2002; Zhu et al., 2009). Furthermore, declining 
SUMO1­RanGAP1 levels were accompanied by corresponding 
increases in nonconjugated RanGAP1 levels. Together, these 
data show that RanBP2 is essential for cell viability.
RanBP2-null cells exhibit chromosome 
missegregation but not mitotic failure
RanBP2  hypomorphic  MEFs  that  express  low  amounts  of 
RanBP2 protein undergo frequent chromosome missegregation 
in the absence of overt transport­related defects (Dawlaty et al., 
2008). This led us to speculate that MEFs without RanBP2 
might die in mitosis as a result of severe segregation errors, a 
phenomenon referred to as mitotic catastrophe (Vitale et al., 
2011). To explore this possibility, chromosome segregation and 
cell fate of RanBP2
F/F MEFs at days 5–7 after Cre infection 
were monitored using time­lapse microscopy. To visualize chromo­
somes, RanBP2
F/F MEFs were transduced with a lentivirus   
expressing H2B–monomeric RFP (mRFP; Malureanu et al., 
2009) before RanBP2 inactivation. Chromosome misalignment, 
chromosome lagging, and chromatin bridging were observed at 
high incidence at day 5 (Fig. 2, A and B). Chromosome lagging 
and chromosome bridging rates were even higher on day 6. In 
addition, more cells were experiencing multiple types of segre­
gation errors (Fig. 2 B). All RanBP2
/ MEFs exhibited chro­
mosome missegregation on day 6, mostly involving small 
numbers of chromosomes. On day 7, we were unable to identify 
any mitotic cells in our cultures. RanBP2
F/F MEFs receiving 
empty virus showed the same types of segregation errors as 
their Cre­treated counterparts but at much lower rates and with­
out progression.
Although the incidence of chromosome missegregation 
was 100% for RanBP2
/ (D6) MEFs, cells never died during 
mitosis. Furthermore, RanBP2
/ (D6) MEFs that we contin­
ued to monitor for 12 h after exit from mitosis rarely died during 
this period (unpublished data), suggesting that mitotic errors   
may not be the primary cause of death of RanBP2
/ MEFs.   
Despite great progress in identifying the components and 
principles  of  the  nucleocytoplasmic  transport  machinery,  in­
depth mechanistic understanding of individual components of 
this system is often difficult to obtain because of the dynamic 
nature of macromolecular transport and the intricacy of the NPC 
(Terry and Wente, 2009). Adding to the complexity is that sev­
eral nucleoporins are not only implicated in nucleocytoplasmic 
transport in interphase but also in the segregation of chromo­
somes during mitosis (Wozniak et al., 2010). One of these pro­
teins is RanBP2 (or Nup358), which is the major nucleoporin 
component of the cytoplasmic filaments of the NPC (Walther   
et al., 2002). In addition to FG repeats, RanBP2 has various 
non­FG domains that are implicated in cargo transport (Wu et al., 
1995; Yokoyama et al., 1995). For instance, RanBP2 has four 
Ran­binding domains (RBDs) and a small ubiquitin­like modi­
fier (SUMO) E3 ligase domain that binds SUMO­modified   
RanGAP1, which have been proposed to stimulate dissociation of 
RanGTP­exportin­cargo and RanGTP­recycling import recep­
tor complexes exiting the central channel (Mahajan et al., 1997; 
Matunis et al., 1998), thereby presumably facilitating both nu­
clear export and nuclear import (Bernad et al., 2004; Engelsma 
et al., 2004; Hutten and Kehlenbach, 2006; Hutten et al., 2008, 
2009). In addition to binding SUMO­RanGAP1, the SUMO E3 
ligase domain has been proposed to mediate cargo sumoylation 
at the cytoplasmic face of the NPC (Pichler et al., 2002; Reverter 
and Lima, 2005). Positioned in the central portion of RanBP2 
are  zinc  finger  domains  that  provide  a  binding  platform  for 
Crm1 (Singh et al., 1999) and that are thought to play a role in 
its transport back into the nucleus (Bernad et al., 2004).
When the nuclear envelope disintegrates and NPCs disassem­
ble at the start of prometaphase, RanBP2­SUMO1–RanGAP1­
Ubc9 subcomplexes disperse into the mitotic cytosol. In certain 
human cell lines, these subcomplexes accumulate at plus ends of 
spindle microtubules (MTs) and, in a Crm1­dependent fashion, at 
unattached kinetochores (Dasso, 2006). In HeLa and RGG cells, 
depletion of RanBP2 causes various mitotic abnormalities, includ­
ing formation of multipolar spindles, chromosome misalignment, 
and mislocalization of several kinetochore­associated proteins   
(Salina et al., 2003; Joseph et al., 2004). Mouse embryonic fibro­
blasts (MEFs) from mice with low amounts of RanBP2 form   
chromatin bridges in anaphase, resulting in aneuploidy (Dawlaty   
et al., 2008). This led to the discovery that RanBP2 sumoylates 
TopII­, thereby targeting this decatenating enzyme to inner centro­
meres to resolve sister chromosomes and prevent bridging.
Although RanBP2 has been implicated in diverse func­
tions related to both transport and mitosis, it is unknown how 
RanBP2 performs its diverse tasks and how critical each func­
tion is for cellular integrity. Here, we have addressed these cen­
tral questions using RanBP2 conditional knockout MEFs and a 
series of RanBP2 domain mutants.
Results
RanBP2 is essential for cell viability
Inactivation  of  RanBP2  causes  early  embryonic  lethality 
(Aslanukov et al., 2006; Dawlaty et al., 2008), but whether 
RanBP2 is essential for viability at the cellular level has not 599 RanBP2 domain requirements in transport and mitosis • Hamada et al.
Multiple nuclear import and export 
pathways are RanBP2 dependent
Earlier work in Drosophila melanogaster Schneider (S2) cells 
showed that depletion of RanBP2 results in nuclear accumula­
tion of polyadenylated gene transcripts, presumably by perturb­
ing efficient recycling of the mRNA export receptor NXF1 to 
the nucleus after cargo release at the NPC (Forler et al., 2004). 
However, RanBP2 depletion in HeLa cells by RNAi had little   
or no impact on mRNA export (Hutten and Kehlenbach, 2006). 
The cause of the observed discrepancy is currently unclear,   
We reasoned that if mitotic errors were indeed not driving cell 
death,  mitotically  inactivated  and  cycling  RanBP2
/  MEFs 
should die at similar rates. To test this, we arrested RanBP2
/ 
MEFs at G2/M with a low dose of  irradiation 72 h after Cre 
transduction (day 3). At this time, RanBP2 protein levels are still 
relatively high, and 75% of cells still segregate their chromosomes 
accurately (vs. 80% of RanBP2
F/F control cells; Fig. 2, C and D). 
However, even though most of the irradiated RanBP2
/ (D3) 
cells had no preexisting chromosome segregation errors, mitotic 
inactivation did not improve cell survival (Fig. 2 E).
Figure  1.  Generation  of  MEFs  lacking 
RanBP2.  (A)  An  overview  of  the  knockout 
strategy. Relevant portions of the RanBP2 hypo-
morphic allele (H), the floxed allele (F), and 
the null allele () are shown. (B) Images of 
RanBP2
F/F MEF cultures taken 8 d after infec-
tion  with  empty  or  Cre-containing  lentivirus. 
(C)  Western  blots  of  MEF  extracts  prepared 
at the indicated times after infection with Cre 
lentivirus. (D) Images illustrating that NPCs of 
RanBP2
/ (D6) MEFs lack RanBP2. (E) Images 
showing that RanGAP1 is unable to localize 
to nuclear pores in RanBP2
/ (D6) MEFs.   
(F) Images showing that SUMO1 fails to deco-
rate the nuclear envelope in RanBP2
/ (D6) 
MEFs.  (G)  Western  blots  of  MEF  extracts  of 
RanBP2
F/F and RanBP2
/ (D6) MEFs probed 
for RanGAP1. Actin served as a loading con-
trol. Bars: (B) 500 µm; (D–F) 5 µm.JCB • VOLUME 194 • NUMBER 4 • 2011   600
Figure 2.  High chromosome missegregation rates but no mitotic catastrophe in MEFs lacking RanBP2. (A) Representative chromosome segregation errors 
in RanBP2
/ (D6) MEFs. Images are from live H2B-mRFP–expressing cells. Bar, 10 µm. (B) Analysis of chromosome segregation errors at days 5 and 6 
after infecting RanBP2
F/F MEFs with empty or Cre-containing lentivirus. RanBP2
+/+ MEFs were used to control for chromosome missegregation that might 
result from expression of Cre recombinase (Loonstra et al., 2001). Error bars represent SEM. Three independent lines were analyzed per genotype/per 
treatment (25 cells per line, 75 total per genotype/per treatment). (C) Chromosome segregation errors at 72 h after infecting RanBP2
F/F MEFs with 
empty or Cre-containing lentivirus. EV, empty vector. (D) Western blot analysis of MEF extracts of RanBP2
F/F and RanBP2
/ (D3) MEFs probed for 
RanBP2. Actin served as a loading control. (E) Survival curves of RanBP2-null and control MEFs with and without  irradiation. RanBP2
F/F MEFs were 
infected with empty or Cre-containing lentivirus and selected with puromycin for 24 h. Cells were then seeded in dishes and either not irradiated or 
exposed to 3,000 rads of  irradiation at 72 h after infection (t = 0 in the graph). Cells were counted at 24-h intervals. n = 5 lines per genotype. Error 
bars represent SD.601 RanBP2 domain requirements in transport and mitosis • Hamada et al.
from the nucleus within 1 h after removal of Dex (Fig. 3 E). 
This result is in accord with earlier studies documenting that 
RanBP2 knockdown causes a mild Crm1­mediated nuclear export 
defect (Bernad et al., 2004; Hutten and Kehlenbach, 2006). RCC1, 
which generates the RanGTP necessary for assembly of nuclear 
export complexes, was properly localized to the nuclear com­
partment (Fig. S1 B). In summary, these data demonstrate that 
RanBP2 loss substantially reduces the efficiency with which vari­
ous transport pathways operate and raise the possibility that cell 
death in the absence of RanBP2 is caused by the combination of 
defects in cellular processes and pathways that require rapid 
nucleocytoplasmic exchange of macromolecules.
C-terminal domains of RanBP2 are not 
essential for cell growth and survival
To dissect the critical RanBP2 domains and to provide insight 
into the in vivo significance of discrete domains within the com­
plex modular architecture of this giant nucleoporin, we wanted 
to stably introduce mutant RanBP2 expression constructs into 
RanBP2
F/F MEFs, inactivate endogenous RanBP2 with pTSIN­
Cre lentivirus, and monitor cells for growth and survival. Stable 
expression of DNA sequences encoding a GFP­tagged human 
RanBP2­1–3224 fusion protein (Fig. 4, A and B) confirmed that 
full­length RanBP2 is able to rescue cell survival in the absence 
of endogenously expressed RanBP2 (Fig. 4, C–F).
Next, we created four RanBP2 mutants (Fig. 4 A): GFP­
RanBP2­2562–2802 (lacking the SUMO E3 ligase domain), 
HA­RanBP2­2553–2838 (consisting of the SUMO E3 ligase 
domain), GFP­RanBP2­1–1889 (N terminus), and GFP­RanBP2­
1930–3224 (C terminus). As expected, only mutants containing 
the NPC­binding domain localized to the nuclear rim (Fig. 4 B 
and  not  depicted).  Of  the  four  mutants,  only  GFP­RanBP2­
2562–2802 and GFP­RanBP2­1–1889 maintained cell growth 
and survival upon inactivation of endogenous RanBP2 expres­
sion (Fig. 4, C and D). PCR analysis confirmed that the floxed 
alleles of the surviving cells had been converted into null alleles 
(Fig. 4 E). Western blot analysis using anti­GFP antibody vali­
dated  that  each  mutant  was  accurately  expressed  (Fig.  4  F; 
Dawlaty et al., 2008). Furthermore, probing of these same blots 
with anti­RanBP2 antibody demonstrated that MEFs expressing 
HA­RanBP2­2553–2802  and  GFP­RanBP2­1–1889  lacked 
endogenous RanBP2 protein and that our GFP­tagged proteins 
were expressed at near endogenous levels. From these experi­
ments, we conclude that the C­terminal RanBP2 domains are 
not essential for cell viability.
A relatively short N-terminal fragment of 
RanBP2 is sufficient for cell viability
To identify the essential domains within the RanBP2 N termi­
nus, we first generated GFP­RanBP2­1–1340, which lacks the 
zinc finger domain cluster (Fig. 5 A). As shown in Fig. 5 (B–E), 
this mutant was capable of rescuing cell growth and survival of 
RanBP2
/ MEFs. Then, three additional truncation mutants 
were designed, focusing on the role of the leucine­rich domain 
(LRD; GFP­RanBP2­600–1340 and GFP­RanBP2­1–1340(735–
800)) and the region containing the three residual FG repeats and 
RBD1 (GFP­RanBP2­1–901). However, none of these mutants 
although it has been proposed that it might be caused by the 
lack of RanBP1 in Drosophila (Hutten and Kehlenbach, 2006). 
To determine the impact of RanBP2 ablation on MEFs, we ana­
lyzed the subcellular distribution of poly(A)
+ RNA in RanBP2
/ 
(D6) and RanBP2
F/F MEFs by FISH with an oligo(dT)50 probe. 
As expected, in control MEFs, poly(A)
+ RNA levels were high 
in the cytoplasm and relatively low in the nucleus (Fig. 3 A). In 
contrast, nuclear accumulation of poly(A)
+ RNA was observed 
in nearly half of the RanBP2
/ (D6) MEFs. Poly(A)
+ RNA 
levels in the cytoplasmic compartment of these cells was clearly 
reduced but never undetectable. The remaining cells had a stain­
ing pattern that was not markedly different from control cells. 
Immunostaining  experiments  revealed  that  RanBP2
/  (D6) 
MEFs had normal Nxf1 localization (unpublished data), implying 
that, unlike in RanBP2­depleted S2 cells, impairment of mRNA 
export does not correlate with aberrant release of the mRNA 
export receptor Nxf1 into the cytoplasm.
Contrasting results have also been obtained on the role of 
RanBP2 in protein import. For instance, in vitro import assays 
on RanBP2­deficient nuclei generated from immunodepleted 
Xenopus laevis egg extracts revealed efficient classical NLS 
(cNLS)–  and  M9­mediated  protein  import,  even  as  nuclear 
pores embedded in these nuclei lacked cytoplasmic fibrils 
(Walther et al., 2002). However, more recent knockdown ex­
periments in HeLa cells revealed that cNLS­ and M9­mediated 
protein import are both less efficient when RanBP2 levels are 
reduced (Hutten et al., 2008, 2009). To thoroughly investigate 
the requirement for RanBP2 in protein import, RanBP2
/ (D6) 
and RanBP2
F/F MEFs were subjected to various kinds of protein 
transport assays.
First, we measured M9­mediated protein import using the 
dexamethasone (Dex)­inducible GR2­GFP2­M9 reporter (Hutten 
et al., 2009). In the absence of Dex, this reporter is localized ex­
clusively in the cytoplasm of both RanBP2
/ (D6) and Ran-
BP2
F/F MEFs. Upon addition of Dex, most RanBP2
F/F MEFs 
accumulated  GR2­GFP2­M9  into  the  nucleus  within  15  min 
(Fig. 3 B). In contrast, a relatively low proportion of RanBP2
/ 
(D6) MEFs did so, with most cells showing near equal GR2­
GFP2­M9 levels throughout the cell, reflecting impaired cargo 
import. A similar approach was used to study cNLS­mediated 
protein import using the GR2­GFP2­cNLS reporter (Hutten   
et al., 2008). Again, whereas most RanBP2
F/F MEFs efficiently 
imported this cargo into the nucleus within 15 min after Dex 
treatment, RanBP2
/ (D6) MEFs failed to do so, with most 
cells exhibiting considerably lower nuclear than cytoplasmic 
fluorescence (Figs. 3 C and S1 A). A relatively small proportion 
of RanBP2
/ (D6) cells retained the ability to import cargo. 
Although these cells had no detectable RanBP2 at the nuclear 
rim (unpublished data), the potential presence of subdetectable 
RanBP2 levels that still might stimulate nuclear import cannot 
be excluded. Importantly, nearly identical results were obtained 
using a Dex­inducible mCherry­labeled chimeric HIV­1–Rev 
protein (Rev­Gr­mCherry [RGmC]) as the reporter (Fig. 3 D; 
Love et al., 1998). The NES of HIV­1–Rev allowed us to use the 
RGmC reporter for analysis of Crm1­mediated nuclear export 
in RanBP2­null cells. RanBP2
/ (D6) MEFs showed a slight, 
but statistically significant, decrease in the ability to export RGmC JCB • VOLUME 194 • NUMBER 4 • 2011   602
containing two point mutations in RBD1 designed to perturb 
Ran binding and potentiation of RanGAP1 activity (Petersen   
et al., 2000). Of these, only GFP­RanBP2­1–1303 was able to 
provide cell viability, indicating that RanGTP binding is essential. 
Thus, the critical RanBP2 functions are concentrated in a   
relatively short N­terminal segment of the protein. We confirmed 
that this fragment cannot recruit RanGAP1 to the cytoplasmic 
face of the NPC (Fig. 5 F) and cannot stabilize SUMO1­ 
RanGAP1 (Fig. S2 B).
was able to rescue cell growth and survival in the absence of 
endogenous RanBP2 (Fig. 5, B and C), even though they were 
properly expressed (Fig. 5 E). GFP­RanBP2­600–1340 did not   
accumulate at the nuclear envelope (Fig. S2 A), indicating that 
NPC binding is essential.
To specifically determine the requirement for RBD1, 
we generated the following three mutants: GFP­RanBP2­1–
1303, which is truncated up to RBD1; GFP­RanBP2­1–1165,   
which  completely  lacks  RBD1;  and  GFP­RanBP2­1–1340*, 
Figure  3.  Multiple  transport  pathways  are 
perturbed in RanBP2-null MEFs. (A) Measure-
ment of poly(A)
+ RNA export from the nucleus 
(n  =  3  MEF  lines  per  genotype;  >50  cells 
per line). (B) Measurement of protein import 
using the Gr2-GFP2-M9 reporter. Three inde-
pendently  generated  cell  lines  were  used 
(RanBP2
F/F, n = 168; RanBP2
/ [D6], n =   
97).  (C)  Measurement  of  protein  import   
using  the  Gr2-GFP2-cNLS  reporter.  Three  in-
dependently generated cell lines were used 
(RanBP2
F/F, n = 167; RanBP2
/ [D6], n = 
157). (D and E) Combined measurement of 
NLS protein import (D) and NES export (E) 
using RGmC. Three independently generated 
cell lines were used. (D) RanBP2
F/F, n = 188; 
RanBP2
/ [D6], n = 173. (E) RanBP2
F/F, n =   
305;  RanBP2
/  [D6],  n  =  332.  (A–D)  *,   
P < 0.01; **, P < 0.001 (two-tailed unpaired 
t test). Error bars indicate SD. C, cytoplasm; 
N, nucleus. Bars, 10 µm.603 RanBP2 domain requirements in transport and mitosis • Hamada et al.
the mutant specifically lacking the SUMO E3 ligase domain of 
RanBP2, fully corrected chromosome alignment errors, it only 
partially corrected chromosome lagging and chromatin bridging. 
Surprisingly, GFP­RanBP2­1–1889 and GFP­RanBP2­1–1340 
had similar corrective potentials as GFP­RanBP2­2562–2802, 
indicating that the SUMO E3 ligase domain is the only C­terminal 
domain with mitotic relevance.
To provide further support for the aforementioned conclu­
sion and to determine whether the SUMO E3 ligase domain can 
The N terminus and the SUMO E3 ligase 
domain of RanBP2 have mitotic functions
To determine the RanBP2 domain requirements for accurate 
chromosome segregation, chromosome movements of RanBP2
/ 
MEFs expressing RanBP2 mutants that rescue cell growth and 
survival were followed by live­cell microscopy. Importantly, 
full­length RanBP2 fully restored the chromosome misalign­
ment, lagging, and bridging errors resulting from complete loss 
of RanBP2 (Fig. 6 A). Although GFP­RanBP2­2562–2802, 
Figure 4.  The RanBP2 SUMO E3 ligase domain is not essential for cell viability. (A) An overview of wild-type and mutant RanBP2 proteins. The LRD includes   
the NPC-targeting domain. CY, cyclophilin homology domain; E3, SUMO E3 ligase domain; KBD, kinesin-binding domain; ZnFs, zinc finger motifs.   
(B) Fluorescent images of RanBP2
/ (D6) MEFs containing the indicated GFP-tagged RanBP2 mutants. Bar, 5 µm. (C) Images of RanBP2
/ (D8) MEFs contain-
ing the indicated expression constructs. Bar, 200 µm. (D) Viability of RanBP2
F/F MEFs expressing the indicated RanBP2 proteins in the presence or absence 
of endogenous RanBP2. (E) PCR genotyping of RanBP2
/ MEFs expressing the indicated RanBP2 proteins showing complete absence of RanBP2
F alleles. 
(F) Western blot analysis of MEFs carrying the indicated GFP-tagged RanBP2 expression constructs. Actin was used as a loading control. MEFs in the first 
three lanes were Cre treated and lacked endogenous RanBP2, whereas MEFs in the last two lanes were not treated with Cre (nonsurviving mutants). The 
antibody against RanBP2 did not detect GFP-1–1889 and GFP-2562–2802 proteins because these mutants lack the antibody epitope (Dawlaty et al., 
2008). Asterisks mark endogenous RanBP2 protein.JCB • VOLUME 194 • NUMBER 4 • 2011   604
Empty vector and mutant SUMO E3 ligase domain (RanBP2­
2553–2838
L2651A;L2653A),  which  lacked  Ubc9  interaction  and 
SUMO E3 ligase activity (Dawlaty et al., 2008), were used as 
controls in these experiments. As shown in Fig. 6 (B and C), 
combined expression of functional SUMO E3 ligase domain 
perform mitotic functions as an independent functional unit in 
the complete absence of endogenous RanBP2, we expressed the 
SUMO E3 ligase domain in RanBP2
/ MEFs that already   
express either GFP­RanBP2­2562–2802 or GFP­RanBP2­1–
1340 and measured the accuracy of chromosome segregation. 
Figure 5.  The N terminus of RanBP2 is suffi-
cient for cell growth and survival. (A) An over-
view of mutant RanBP2 proteins. 1–1340*, 
1–1340 containing a W1211R and K1212M 
double mutation in RBD1 designed to disrupt 
Ran  binding  and  potentiation  of  RanGAP1. 
(B) Images of RanBP2
/ (D8) MEFs contain-
ing the indicated expression constructs. Bar, 
200 µm. (C) Viability of RanBP2
F/F MEFs ex-
pressing the indicated RanBP2 proteins in the 
presence or absence of endogenous RanBP2. 
(D)  PCR  analysis  of  DNA  isolated  from  vi-
able  RanBP2
/  (D6)  MEFs  expressing  the 
indicated RanBP2 proteins. (E) A Western blot 
of  MEFs  carrying  the  indicated  GFP-tagged 
RanBP2  expression  constructs.  Actin  was 
used as a loading control. MEFs in lanes 2 
and 5 were Cre treated (lacking endogenous 
RanBP2),  whereas  MEFs  in  the  remaining 
lanes  were  untreated.  (F)  RanBP2
/  MEFs 
expressing GFP-RanBP2-1–1340 and control 
MEFs stained for RanGAP1. Bar, 5 µm.605 RanBP2 domain requirements in transport and mitosis • Hamada et al.
and either GFP­RanBP2­2562–2802 or RanBP2­1–1340 cor­
rected both chromosome lagging and chromatin bridging errors 
to rates seen in RanBP2
F/F MEFs expressing normal amounts of 
endogenous RanBP2. No such corrective effect was observed in 
empty vector or HA­RanBP2­2553–2838
L2651A;L2653A–transduced 
cells. These data demonstrate that the RanBP2 SUMO E3 ligase 
domain is the only C­terminal domain that regulates accurate 
chromosome segregation and suggest that this domain is func­
tionally autonomous. Given the strong corrective effect of the 
SUMO E3 ligase domain on chromosome missegregation, we 
wondered whether its expression in RanBP2
/ MEFs contain­
ing GFP­RanBP2­1–1165 might restore growth and survival, 
but this was not the case (Fig. S3).
The mitotic phenotype of RanBP2
/ (D6) MEFs is dif­
ferent from that of RanBP2
/ MEFs expressing GFP­RanBP2­
1–1340 in two ways. First, RanBP2
/ MEFs have increased 
rates of chromosome misalignment, and GFP­RanBP2­1–1340 
RanBP2
/ MEFs do not. Second, although both RanBP2
/ 
MEFs and GFP­RanBP2­1–1340 RanBP2
/ MEFs have in­
creased rates of chromosome lagging and chromatin bridging, 
the increases are much more profound in RanBP2
/ MEFs. 
These findings suggest that the RanBP2 N terminus also con­
tributes to the chromosome segregation process. Previous stud­
ies of HeLa cells have documented that depletion of RanBP2 by 
RNAi perturbs mitotic spindle formation and loading of certain 
mitotic checkpoint proteins onto kinetochores in early mitosis 
(Salina et al., 2003; Joseph et al., 2004; Arnaoutov et al., 2005). 
However, no such mitotic defects were detectable in RanBP2
/ 
(D6) MEFs (Fig. S1 C and not depicted). Furthermore, RanBP2 
itself is found at kinetochores in a subset of mammalian cell 
lines, including HeLa cells (Joseph et al., 2004; Arnaoutov and 
Dasso, 2005; Arnaoutov et al., 2005), but neither endogenous 
RanBP2  nor  GFP­RanBP2­1–1340  was  localized  to  kineto­
chores in mitotic MEFs (unpublished data). Together, these data 
suggest that the RanBP2 N terminus may exert its effect on 
chromosome segregation through an unknown mitotic function 
or indirectly through a nucleocytoplasmic transport function.
Ran binding ability of RanBP2 is required 
for adequate cNLS protein import
Next, we used our collection of RanBP2 mutants to investigate 
the domain requirements for each of the transport pathways 
that  are  defective  in  the  absence  of  endogenous  RanBP2. 
Restoration of cell viability by GFP­RanBP2­1–1340 coincided 
with near complete correction of the bulk mRNA export defect 
of RanBP2
/ (D6) MEFs (Fig. 7 A). However, strong correc­
tive effects were also established by GFP­RanBP2­1–1340* 
and GFP­RanBP2­1–1165, two mutants that were unable to 
restore cell viability, suggesting that efficient mRNA export 
does not depend on RanBP2’s Ran binding ability. These data 
Figure 6.  The RanBP2 SUMO E3 ligase do-
main  acts  autonomously  in  mitosis.  (A)  An 
analysis  of  segregation  errors  in  RanBP2
/ 
(D6) MEFs and RanBP2
/ MEFs expressing 
the indicated RanBP2 mutants (n = 3 MEF lines 
per mutant; 25 cells per line). Error bars in-
dicate SEM. All mutants are P < 0.05 versus 
RanBP2
/  (D6)  MEFs  (
2  test).  (B)  An  inci-
dence  of  chromosome  segregation  errors  in 
GFP-RanBP2-2562–2802  RanBP2
/  MEFs 
expressing wild-type or mutant SUMO E3 li-
gase domain (n = 3 MEF lines evaluated for 
each mutant combination; 20–25 cells per 
line). (C) An incidence as described in B but 
for  GFP-RanBP2-1–1340  RanBP2
/  MEFs. 
(B  and  C)  *,  P  <  0.05  versus  GFP-RanBP2-
2562–2802  RanBP2
/  MEFs  carrying 
empty expression vector (
2 test). Error bars 
indicate SEM.JCB • VOLUME 194 • NUMBER 4 • 2011   606
Figure 7.  cNLS-mediated import selectively requires Ran binding ability. (A) An analysis of poly(A)
+ RNA distribution in RanBP2
/ (D6) MEFs expressing 
the indicated RanBP2 mutants (n = 3 MEF lines per mutant). 1–1340*, 1–1340 containing a W1211R and K1212M double mutation in RBD1 designed 
to disrupt Ran binding and potentiation of RanGAP1. (B) Measurement of protein import using the Gr2-GFP2-cNLS reporter. C, cytoplasm; N, nucleus.   
(C) Measurement of protein import using the NES-GFP2-cNLS reporter. (D) In vitro import of FITC-labeled cNLS-BSA (at 50 mM importin-). (A–C) Error bars 
indicate SD. (B and C) *, P < 0.01; **, P < 0.001 (two-tailed unpaired t test). n = 3 MEF lines per mutant genotype; 50 cells per line. Bars,10 µm.607 RanBP2 domain requirements in transport and mitosis • Hamada et al.
nuclear rim in RanBP2
/ (D6) MEFs and RanBP2
/ (D6) 
MEFs  expressing  RanBP2  mutants  without  an  (functional) 
RBD (Fig. 8 A). Western blot analysis demonstrated that this 
decline was not caused by a decrease in overall importin­ 
levels (Fig. S5 F). These data suggested that Ran­dependent 
docking of importin­ to the RBD of RanBP2 at the cytoplas­
mic face of the NPC might be essential for efficient cNLS­
mediated nuclear protein import. Data from two additional 
experiments support this model. First, RanBP2
/ (D6) MEFs 
expressing  GFP­RanBP2­1–1340*  or  GFP­RanBP2­1–1165 
showed a strong increase in nuclear import of cNLS­BSA­FITC 
cargo when in vitro import assays were conducted at a twofold 
higher importin­ concentration (Fig. 8 B). Second, in a blot 
overlay assay (Delphin et al., 1997), GFP­RanBP2­1–1340 inter­
acted with importin­ in the presence but not in the absence of 
RanGTP, whereas GFP­RanBP2­1–1340* or GFP­RanBP2­1–
1165 was defective in binding importin­ both in the presence 
and absence of RanGTP (Fig. 8 C).
Crm1 is known to accumulate at the cytoplasmic face of the 
NPC in a RanBP2­dependent fashion, presumably to allow for   
efficient recycling of Crm1 to the nucleus after cargo release   
(Engelsma et al., 2004). However, RanBP2 mutants that fully re­
stored  the  NES­mediated  export  defect  of  RanBP2
/  MEFs 
showed weak nuclear rim staining for Crm1 (Fig. 8, D and E), im­
plying that accumulation of Crm1 at the cytoplasmic face of the 
pore is not a critical step in the NES transport pathway. The afore­
mentioned analysis indicated that the RanBP2 domain responsi­
ble for accumulation of Crm1 at cytoplasmic filaments is located 
in the C­terminal half of the protein. RanBP2
/ MEFs express­
ing GFP­RanBP2­2562–2802 showed normal Crm1 staining 
(Fig. 8, D and E), suggesting that Crm1 binding to RanBP2 fila­
ments does not involve the SUMO E3 ligase domain.
Discussion
In this study, we have used a RanBP2 conditional knockout 
approach in MEFs to dissect the critical cellular functions of 
RanBP2. We show that RanBP2 is essential for viability at the 
cellular level and provides compelling evidence to suggest that 
cell death is associated with transport defects rather than mitotic 
failure.  Rescue  experiments  in  which  we  expressed  various 
RanBP2 mutant constructs before the inactivation of endoge­
nous RanBP2 not only revealed the RanBP2 domains critical 
for cell growth and survival but also provided mechanistic in­
sight into the dependence of various major transport pathways 
on these domains.
A link between RanBP2 and mRNA export 
in mammalian cells
A hitherto unrecognized role of mammalian RanBP2 in mRNA 
export was uncovered by our experiments. Previously, such a 
role had only been demonstrated in flies (Forler et al., 2004). 
There, RanBP2 serves as a major docking site for the mRNA 
transport receptor Nxf1. In binding to Nxf1, RanBP2 prevents 
Nxf1 diffusion into the cytoplasm after cargo release, allowing 
for efficient recycling of this transport receptor. Nxf1 is not mis­
localized to the cytoplasm in RanBP2
/ MEFs, implying that 
also imply that rescue of nuclear mRNA export is not suffi­
cient to restore viability in the absence of endogenous RanBP2. 
In contrast, GFP­RanBP2­600–1340 established no corrective 
effect, indicating that the LRD is essential for mRNA export. 
Furthermore, GFP­RanBP2­1–901 had only a slight corrective 
effect, suggesting the involvement of FG repeats in efficient 
mRNA export.
Restoration of cell growth and survival by GFP­RanBP2­
1–1340 also concurred with near complete correction of the 
GR2­GFP2­M9 nuclear import defect (Fig. S4 A). Because 
fluorescence from GFP­RanBP2­1–1340 and other GFP­tagged 
RanBP2 mutants was very low relative to that of GR2­GFP2­M9, 
it did not complicate the analysis (Fig. S5 A). Similar results 
were  obtained  for  RanBP2
/  (D6)  MEFs  expressing  GFP­
RanBP2­1–1340* and GFP­RanBP2­1–1165, implying that 
cell death is not related to M9­mediated protein import and   
that RBD1 is not essential for this type of protein import.   
In  vitro  import  assays  on  RanBP2
/  MEFs  expressing  the 
aforementioned  mutants  yielded  similar  results  (Figs.  S4   
[B and C] and S5 B), confirming that M9­mediated import is 
RBD1 independent. In contrast, GFP­RanBP2­600–1340 and 
GFP­RanBP2­1–901 had no corrective effects, indicating that 
efficient M9­mediated transport is dependent on the LRD and 
the presence of the region with several FG repeats.
GFP­RanBP2­1–1340  also  restored  efficient  import  of 
GR2­GFP2­cNLS  reporter  protein  (Fig.  7  B).  In  contrast,   
GFP­RanBP2­1–1340* and GFP­RanBP2­1–1165 did not, imply­
ing that RBD1 is required for efficient cNLS­mediated protein 
import. The validity of these findings was confirmed using the 
shuttling reporter protein NES­GFP2­cNLS (Fig. 7 C). Further­
more, in in vitro import assays with FITC­labeled recombinant 
cNLS­BSA as a substrate, efficient cargo import occurred in 
RanBP2
/ MEFs expressing GFP­RanBP2­1–3224 or GFP­
RanBP2­1–1340 but not in those expressing GFP­RanBP2­1–
1340 versions that cannot bind Ran (Figs. 7 D and S5 C). Thus, 
multiple independent assays indicate that RanBP2 Ran binding 
ability is critical for efficient cNLS­mediated protein import. 
We found that RanBP2 Ran binding ability is also essential for 
efficient in vitro import of Snail (Fig. S5 D), a protein that 
binds directly to importin­ and does not require importin­ 
(Yamasaki et al., 2005). Crm1­mediated protein export, in con­
trast, does not seem to be dependent on RanBP2 Ran binding 
ability (Fig. S5 E).
RBD1 of RanBP2 retains importin- at 
nuclear pores
Ran binding by RanBP2 is unlikely to play a direct role in nu­
clear import of cNLS protein importin­/ transport complexes 
because these complexes lack Ran. However, recycling of   
importin­ and ­ to the cytoplasm after cargo release in the 
nucleus is Ran dependent (Wente and Rout, 2010). Immunostain­
ing experiments for importin­ and ­ revealed that neither trans­
port  factor  was  mislocalized  in  RanBP2
/  (D6)  MEFs  and 
RanBP2
/ (D6) MEFs expressing GFP­RanBP2­1–1340* (un­
published data). However, using a mild fixation procedure that 
allows for the removal of soluble protein fractions before stain­
ing, we observed a dramatic decline in importin­ levels at the JCB • VOLUME 194 • NUMBER 4 • 2011   608
Figure 8.  Importin- accumulation at the NPC is dependent on RanBP2 RBD1. (A) Images of RanBP2
/ (D6) MEFs expressing the indicated RanBP2 
mutants immunostained for importin-. Nuclei were visualized with Hoechst. 1–1340*, 1–1340 containing a W1211R and K1212M double mutation in 
RBD1 designed to disrupt Ran binding and potentiation of RanGAP1. (B) In vitro import of FITC-labeled NLS-BSA into RanBP2
/ (D6) MEFs expressing 
the indicated RanBP2 mutants. Import assays were conducted at a twofold higher importin concentration as described in Fig. 7 D. (C) Blot overlay assay 
measuring binding of importin- to various N-terminal RanBP2 fragments in the absence or presence of RanGTP. (D) Images of digitonin-permeabilized 
RanBP2
/ MEFs expressing the indicated RanBP2 mutants stained for Crm1. Nuclei were visualized with Hoechst staining. (E) Quantification of Crm1 
signal at the nuclear rim. Mean values of 10 cells per line are presented. Error bars represent SEM. **, P < 0.001 versus RanBP2
/ cells expressing GFP-
1–3224 (two-tailed unpaired t test). Bars, 10 µm.609 RanBP2 domain requirements in transport and mitosis • Hamada et al.
interpretation  is  our  finding  that  the  importin­/–mediated 
protein import defect observed in the absence of RBD1 is largely 
corrected when the importin­ concentration in in vitro import 
assays is raised.
RanBP2
/ MEFs expressing RanBP2­1–1340 are viable 
and have quite normal NES protein export rates, even though they 
fail to accumulate Crm1 at the cytoplasmic face. This, together 
with the finding that RanBP2
/ MEFs expressing RanBP2­1–
1340 show a normal Crm1 distribution pattern, suggests that the 
docking of Crm1 to RanBP2 is not critical for efficient cargo un­
loading and/or Crm1 recycling. The RanBP2 domains that medi­
ate Crm1 accumulation at pores reside in the C­terminal half of 
the protein; our data suggest that the SUMO E3 ligase domain is 
not implicated. Interestingly, we find that transportin­mediated 
protein import and Nxf1­mediated mRNA export rely on the 
same RanBP2 domains. Because transportin recycles Nxf1 back 
into the nucleus after mRNA is discharged at the cytoplasmic side 
of the pore, it is tempting to speculate that impaired mRNA ex­
port is a result of inadequate transport receptor recycling rather 
than inefficient release of mRNA cargo at the cytoplasmic side of 
the pore. As mentioned, we did not observe an increase in the 
steady­state  levels  of  Nxf1  in  the  cytoplasmic  compartment, 
which, at the surface, argues against this possibility. However, if 
mRNA release and Nxf1 recycling were coupled events, the dis­
tribution of Nxf1 would be expected to remain unchanged.
An RNAi study in HeLa cells has suggested that transpor­
tin becomes rate limiting for efficient M9 protein import when 
RanBP2 levels are low (Hutten et al., 2009), but how RanBP2 
facilitates M9 protein import is unknown. Our structure–function 
analysis demonstrates that the RanBP2 N terminus can largely 
sustain efficient M9­mediated export in the absence of RBD1 
but not when the three FG motifs or the NPC­anchoring domain 
is deleted. The fact that RBD1 is not required indicates that 
RanBP2 does not exert its effect by stimulating release of recycled 
transportin at the cytoplasmic face of the pore. Perhaps RanBP2 
FG motifs play a role in retaining transportin at the NPC after 
GTP hydrolysis to allow for efficient loading of M9­containing 
cargo. We were unable to test this potential mechanism because 
antibodies detecting mouse transportin are not available.
RanBP2 in mitosis
Four observations presented here suggest that the chromosome 
segregation errors resulting from loss of RanBP2 are unlikely to 
cause cell death. First, similar cell death kinetics were observed 
in cycling and mitotically inactivated RanBP2­null MEFs. Impor­
tantly, at the time of mitotic inactivation, most RanBP2­null 
MEFs accurately separated their chromosomes. Second, unlike 
cells  lacking  mitotic  checkpoint  proteins  such  as  Mad2  and 
BubR1 (Dobles et al., 2000; Malureanu et al., 2009), RanBP2­
null MEFs did not die by mitotic catastrophe, a type of cell 
death that occurs in mitosis after a failed chromosome segre­
gation attempt (Castedo et al., 2004). Third, chromosome 
missegregation events in RanBP2­null MEFs typically involved 
relatively small numbers of chromosomes and rarely resulted in 
cell death within 12 h after completing cell division. Fourth, the 
RanBP2­1–1340 fragment repairs transport and viability but 
still has frequent mitotic errors.
the mechanisms by which RanBP2 controls mRNA export in 
insect and mouse cells may have diverged. The basis for this di­
vergence may involve a differential requirement for RBDs of 
RanBP2. Insect cells are thought to be highly dependent on these 
domains for cargo release into the cytoplasm because RanBP1, 
the functional equivalent of RanBP2 RBDs, is lacking (Villa 
Braslavsky  et  al.,  2000). Although  RanBP2
/  MEFs  and 
RanBP2 knockdown Drosophila cells show robust nuclear accu­
mulation of poly(A)
+ RNA (Forler et al., 2004), in both cases 
there is residual cytoplasmic poly(A)
+ staining, indicating that 
RanBP2 is a facilitator rather than an indispensible component 
of this pathway. In addition to Nxf1, mRNPs contain various 
shuttling binding proteins (Strambio­De­Castillia et al., 2010), 
whose potential mislocalization in RanBP2
/ MEFs might be 
indirectly implicated in nuclear accumulation of poly(A)
+ RNA.
New insights into key actions of RanBP2 
from trimmed filaments
RanBP2 is thought to provide a platform where RanGTP­ 
exportin­cargo and RanGTP–importin complexes exiting at the 
cytoplasmic side of the NPC dock to disassemble via RanBP1­ 
and RanGAP1­stimulated GTP hydrolysis on RanGTP (Yaseen 
and Blobel, 1999). In this model, GTP hydrolysis is not only 
stimulated by soluble RanBP1 and RanGAP1 but also by 
RanBP2­bound RanGAP1 and RBDs with RanBP1­like proper­
ties (Mahajan et al., 1997; Matunis et al., 1998; Villa Braslavsky 
et al., 2000). Furthermore, RanBP2 is thought to mediate effi­
cient exportin recycling to the nucleus and efficient reloading of 
cargo onto newly exported importins (Bernad et al., 2004; 
Hutten and Kehlenbach, 2006; Hutten et al., 2008).
Here, we have critically tested these and other presumed 
RanBP2 functions in vivo using RanBP2
/ MEF lines express­
ing various RanBP2 mutants. The absence of endogenous RanBP2 
is key here because, as a result of the catalytic nature of the pro­
posed RanBP2 functions, small amounts of protein that may re­
main with RNAi approaches could easily mask certain RanBP2 
functional  deficiencies.  Particularly  insightful  was  a  short   
N­terminal RanBP2 fragment that restored cell viability and 
corrected  all  transport  defects  of  RanBP2­null  cells,  despite 
only containing the NPC­anchoring domain, three FG repeats, 
and RBD1. However, when RBD1 was mutated, cNLS protein 
import rates dropped substantially, and cells were unable to sus­
tain growth and survival. The finding that M9­mediated protein 
import, mRNA export, and NES­mediated export were largely 
unaffected indicates a selective rather than a generic require­
ment of transport pathways for RanGTP binding sites at the   
cytoplasmic face of the NPC. When the sole RBD is mutated   
or depleted, RanGTP–importin­ binding was perturbed, and 
importin­ failed to accumulate at nuclear pores, suggesting 
that a critical function of this RanBP2 domain is to concentrate 
importin­ at the cytoplasmic face of the pore. The most plausible 
scenario is that in the absence of RBD1, RanGTP–importin­ 
complexes recycling from the nuclear compartment fail to dock 
at the cytoplasmic face of the pore and diffuse into the cyto­
plasm. The drop in importin­ at the cytoplasmic face might 
impair the rate at which unloaded importin­ molecules can 
reload  and  start  a  new  import  cycle.  Consistent  with  this   JCB • VOLUME 194 • NUMBER 4 • 2011   610
detection of RanBP2
F and RanBP2
 alleles have been previously described 
(Dawlaty et al., 2008). An inverted microscope (TMS; Nikon) with a 10× 
Ph1 dual lens objective was used to acquire images of MEF cultures.
Western blot analysis, indirect immunofluorescence, and  
confocal microscopy
Western blot analysis (Kasper et al., 1999) and indirect immunofluores-
cence (Kasper et al., 1999; Taylor et al., 2001) were performed as previ-
ously described. Standard fixations for immunostainings were performed 
with 3% PFA for 15 min at RT. For nuclear pore localization studies, cells 
were fixed with 1% PFA for 15 min at RT (mild fixation). For kinetochore   
localization studies, cells were fixed with 1% PFA for 5 min at RT. Fixation 
was followed by permeabilization in 0.2% Triton X-100 for 10 min. For 
staining of Crm1 at the cytoplasmic face of the NPC, cells were permeabi-
lized with 0.4 µg/ml digitonin for 5 min and then fixed with 3% PFA for 
15 min at RT (no Triton X-100 permeabilization). A laser-scanning micro-
scope (LSM 510 v3.2SP2; Carl Zeiss) with Axiovert 100M (Carl Zeiss) 
and c-Apochromat 100 or 63× objectives was used to analyze immuno-
stained cells and acquire images. Quantification of fluorescence was per-
formed on confocal images using ImageJ software (National Institutes of 
Health). Fluorescence intensity at the nuclear rim was measured at four points 
per cell and averaged. Fluorescence intensity inside the nucleus and in the 
intercellular background was subtracted from the mean nuclear rim value.
Antibodies
The  following  antibodies  were  used:  rabbit  anti–hRanBP2-2500–3224 
(Dawlaty et al., 2008) and mouse anti-RanBP2 (D-4; Santa Cruz Biotechnol-
ogy, Inc.; Fig. 1, E and F); rabbit anti-RanGAP1 (provided by M. Dasso, 
National Institutes of Health, Bethesda, MD); goat anti-RanGAP1 (N-19; 
Santa Cruz Biotechnology, Inc.); mouse anti-GFP (B-2; Santa Cruz Biotech-
nology, Inc.); rabbit anti-hCrm1 (provided by M. Fornerod, Erasmus Univer-
sity,  Rotterdam,  Netherlands);  mouse  anti-MAb414  (Covance);  rabbit 
anti–CENP-E (provided by D. Cleveland, Ludwig Institute for Cancer Re-
search, La Jolla, CA); rabbit anti-Bub1 (Jeganathan et al., 2007); rabbit 
anti-Mad2 (Malureanu et al., 2010); goat antiimportin- (C-19; Santa Cruz 
Biotechnology, Inc.); rabbit anti-SUMO1 (Cell Signaling Technology); mouse 
anti-SUMO2/3 (Zhang et al., 2008); mouse anti– actin (A5441; Sigma-
Aldrich); and goat anti-RCC1 (N-19; Santa Cruz Biotechnology, Inc.).
Live-cell imaging
Analyses of chromosome missegregation and mitotic timing by live-cell im-
aging were performed as previously described (Jeganathan et al., 2007; 
Malureanu et al., 2009). In brief, MEFs were transduced with a lentivirus 
encoding an mRFP-tagged H2B to allow for visualization of chromosomes 
by fluorescence microscopy. Transduced cells were seeded onto 35-mm 
glass-bottomed culture dishes. Approximately 24 h later, chromosome move-
ments of MEFs progressing through an unchallenged mitosis were followed 
at interframe intervals of 3 min using an Axio Observer Z1 system equipped 
with CO2 Module S, TempModule S, Heating Unit XL S, a Pln Apo 63×/1.4 
oil differential interference contrast III objective, AxioCam MRm camera, 
and AxioVision 4.6 software (Carl Zeiss). PowerPoint software (Microsoft) 
for Macintosh was used for image processing, and Prism software (version 
4.0a; GraphPad) for Macintosh was used for statistical analysis. Three inde-
pendent clones per genotype were used unless otherwise noted.
Plasmids
pEGFP-C2 full-length human RanBP2 was previously described (Joseph and 
Dasso, 2008). All RanBP2 mutants were constructed from pEGFP-C2 full-
length human RanBP2 using standard cloning procedures and verified by 
DNA sequencing. RanBP2-1–1340* contains W1211R and K1212M mu-
tations  in  RBD1  of  RanBP2.  These  residues  correspond  to  W67R  and 
K68M mutations in murine RanBP1, which have been shown to disrupt the 
RanBP1’s ability to bind Ran and potentiate RanGAP1 activity (Petersen   
et  al.,  2000).  For  stable  expression  of  wild-type  and  mutant  RanBP2   
cDNAs, we used Tol2-based transposition (Balciunas et al., 2006) using 
pKTol2C-hygromycin and pKC-Tol2 (provided by S. Ekker, Mayo Clinic, 
Rochester, MN). pKTol2C-hygromycin was generated from pKTol2C-EGFP 
as follows: EGFP was removed by XhoI–BglII digestion and replaced with 
an adaptor with multiple cloning sites to create pKTol2C–multiple cloning 
site. Herpes simplex virus–thymidine kinase promoter–hygromycin resis-
tance gene–herpes simplex virus thymidine kinase pA cassette was PCR 
amplified  with  primers  5-TTATTTACCGGTCTGCTTCATCCCCGTGGC-3 
and 5-TTATTTGCTAGCTTGCGCCAGAAATCCGCG-3 using pJTI Fast   
(Invitrogen) as a template. AgeI–NheI-digested PCR product was inserted into 
AgeI–NheI-opened pKTol2C-MCS to generate pKTol2C-hygromycin. HA-
tagged  RanBP2-2553–2838  and  RanBP2-2553–2838
L2561A;L2563A  were 
Using RanBP2 hypomorphic MEFs that have 20% of 
normal RanBP2 levels, we previously identified a key role for 
the RanBP2 SUMO E3 ligase domain in chromosome segrega­
tion  (Dawlaty  et  al.,  2008).  Our  structure–function  analysis 
demonstrates that it is the sole domain in the C­terminal two 
thirds  of  the  protein  implicated  in  mitosis.  Our  finding  that 
RanBP2­null cells show near complete correction of accurate 
chromosome segregation upon coexpression of the SUMO E3 
ligase domain and RanBP2­1–1340 indicates that the E3 ligase 
domain can perform its mitotic functions in an autonomous 
fashion. Mutation of the SUMO E3 ligase domain precludes 
such  correction,  revealing  that  it  exerts  its  corrective  effect 
through its ability to sumoylate TopII­ and potentially other 
mitotic regulators (Dawlaty et al., 2008) or through regulation 
of the mitotic functions of RanGTPase via RanGAP1 (Arnaoutov 
and Dasso, 2005).
Our finding that the N­terminal RanBP2 fragment that 
mediates cell survival fully restores proper chromosome mis­
alignment in RanBP2­null MEFs suggested that this fragment 
might have an independent role in mitosis. Interestingly, in cer­
tain human cell lines, RanBP2 accumulates at kinetochores in a 
Crm1­dependent fashion, presumably to stabilize kinetochore–MT 
attachments (Joseph et al., 2004; Arnaoutov et al., 2005). 
However, two observations suggest that the N terminus of 
RanBP2 does not exert its corrective effect on chromosome–MT 
attachment through this mechanism in MEFs. First, the N­terminal 
fragment  lacks  Crm1  binding  ability.  Second,  neither  the   
N terminus of RanBP2 nor endogenous RanBP2 accumulates at 
kinetochores in MEFs. Perhaps the N terminus acts to stabilize 
MT–kinetochore attachments in a Crm1­independent fashion. 
The LRD has been suggested to bind and regulate the dynamics 
of MTs (Joseph and Dasso, 2008). Alternatively, the N terminus 
may regulate the activities of RanGTPase in MT–chromosome 
attachment by stimulating RanGTP hydrolysis of cargo com­
plexes containing spindle assembly factors (Dasso, 2002). 
Finally, RanBP2 depletion in cancer cell lines interferes with 
kinetochore targeting of proteins implicated in mitotic check­
point signaling and proper MT–kinetochore attachment. How­
ever, no such defect was observed in MEFs lacking RanBP2.
In conclusion, our data suggest that docking of recycling 
importin­–RanGTP complexes to RanBP2 RBDs at the cyto­
plasmic fibrils of NPCs is necessary to achieve importin­–
mediated nuclear import rates high enough to sustain cell 
growth and survival. Whether cell death resulting from loss of 
this docking ability involves inadequate nuclear import of   
a broad spectrum of nuclear proteins or just a small subset   
of  perhaps  highly  dynamic  shuttling  proteins  remains  to   
be determined.
Materials and methods
Generation and culture of RanBP2 conditional knockout MEFs
We created heterozygous RanBP2 conditional knockout mice (RanBP2
+/F 
mice) by interbreeding RanBP2 hypomorphic mice (RanBP2
H/H mice) with 
FLPeR  transgenic  mice  purchased  from  The  Jackson  Laboratory.  MEFs 
were subsequently generated from 13.5-d-old embryos of RanBP2
+/F fe-
males mated with RanBP2
+/F males. Three independent RanBP2
F/F MEF 
lines were obtained and immortalized by transduction with SV40 large   
T antigen–containing murine stem cell virus retrovirus. Primers used for the 611 RanBP2 domain requirements in transport and mitosis • Hamada et al.
Blot overlay assays
GFP-RanBP2-1–1340,  GFP-RanBP2-1–1340*,  and  GFP-RanBP2-1–1165 
were immunoprecipitated from MEF lines stably expressing these proteins 
as previously described (Kasper et al., 1999). The precipitated proteins 
were separated by SDS-PAGE and transferred to Immobilon-P membrane. 
Overlay binding assays were then performed essentially as previously de-
scribed (Delphin et al., 1997). In brief, membranes with renatured proteins 
were incubated for 30 min at RT with 20 nM recombinant His–importin- 
in the presence of 40 nM RanGTP or RanGDP or in the absence of Ran. 
Blots were then washed with 0.1% Tween 20 and 4 mM DTT in PBS and 
probed for His–importin- using mouse anti–penta-His (QIAGEN). RanGTP 
and RanGDP were prepared by incubating 1 µM Ran with 1 mM GTP or 
GDP in 10 mM EDTA, 2 mM ATP, 4 mM DTT, and 50 mM Hepes, pH 7.4, 
for 30 min at 30°C. Reactions were stopped by adding MgCl2 to the final 
concentration of 15 mM at 4°C.
Online supplemental material
Fig. S1 shows that the subcellular localization of RCC1 and mitotic check-
point proteins is normal in RanBP2-null MEFs. Fig. S2 shows that SUMO1 
modification of RanBP1 requires the SUMO E3 ligase domain of RanBP2. 
Fig. S3 shows that RanBP2 SUMO E3 ligase activity cannot rescue cell 
death of GFP-RanBP2-1–1165 RanBP2
/ MEFs. Fig. S4 shows that M9-
mediated protein import is not dependent on RBD1 of RanBP2. Fig. S5 
contains results of various transport-related experiments performed on RanBP2 
mutant MEFs. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201102018/DC1.
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